Biovica International (STO:BIOVIC-B; FRA:911) announced that it has partnered with Outcomes4Me to support post-menopausal patients with hormone (HR)-positive metastatic breast cancer (mBC) in understanding treatment...
Biovica International (STO:BIOVIC-B; STO:BIOVIC.B; FRA:911) has announced the signing of a significant work order for TKa testing services, valued at 2.3 MSEK. The agreement has been made with a UK-based...